ASHA GARCIA: Open Payments
NPI 1982117370 · BROOKLYN, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,089 in 99 payments from 16 companies in 2025. Trend: 2023 $227 · 2024 $788 · 2025 $2,089
Food & beverage: $2,089
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 32 | $545 |
| Axsome Therapeutics, Inc. | 13 | $350 |
| Alkermes, Inc. | 13 | $319 |
| Vanda Pharmaceuticals Inc. | 7 | $189 |
| Otsuka America Pharmaceutical, Inc. | 5 | $186 |
| Braeburn Inc. | 6 | $99 |
| Lundbeck LLC | 5 | $92 |
| E.R. Squibb & Sons, L.L.C. | 5 | $83 |
| Indivior Inc. | 3 | $52 |
| Janssen Pharmaceuticals, Inc | 3 | $51 |
Products named: VRAYLAR, Auvelity, REXULTI, ARISTADA, LYBALVI, FANAPT, BRIXADI, COBENFY.
Industry payments across NY — which companies pay providers there.
